Kriya Therapeutics Funding & Investors
Kriya Therapeutics is a transformative gene therapy company with the intent to expand gene therapy to broader disease indications leveraging in house manufacturing capabilities and novel therapeutic designs.
kriyatherapeutics.comTotal Amount Raised: $600,499,968
Kriya Therapeutics Funding Rounds
Series C
$150,000,000
Series C Investors
Patient Square CapitalSeries C
$270,000,000
Series C Investors
Bluebird VenturesLightswitch CapitalAlumni VenturesQVT FinancialJDRF T1D FundPatient Square CapitalForesite CapitalTranshuman CapitalNarya CapitalDexcel PharmaCAM CapitalSeries B
$100,000,000
Series B Investors
Woodline PartnersAlumni VenturesQVT FinancialJDRF T1D FundAmplo ManagementPatient Square CapitalTranshuman CapitalDexcel PharmaBluebird VenturesHongkouForesite CapitalNarya CapitalCAM CapitalSeries A
$80,500,000
Series A Investors
Bluebird VenturesQVT FinancialJDRF T1D FundSahsen VenturesAmplo ManagementForesite CapitalNarya CapitalTranshuman CapitalPaul ManningDexcel Pharma
Funding info provided by Diffbot.